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Abstract
Many women who have, or are at risk for, BRCA 1/2 mutations or breast cancer decline
prophylactic surgery, but questions remain as to how they make and experience these decisions.
Our methods consisted of interviewing 32 women for 2 hr each; 19 were tested, 20 were
symptomatic. Our results showed that these surgical options forced women to confront questions,
involving stresses and uncertainties, regarding: implications of test results, prognoses with and
without surgery, and effects of surgery (e.g., on self-image). Given these dilemmas, many women
turned to doctors who then ranged in what and how they communicated about these issues, and
how strongly they offered input. Some patients felt disappointed at provider non-directiveness,
while others found providers too directive. Patients turned to family members and friends, who
also ranged in how and what they communicated, and whether they agreed with the patient and/or
each other. Many women turned to patient communities, but then had to decide how involved to
be, and what information to provide or accept. These data suggest that providers and others may
need to be more aware of the series of questions, involving stresses and uncertainties, that these
women face, and the complex roles providers themselves may play. These data highlight needs for
physicians to be able to address these issues flexibly, gauging patient preferences for information
and paternalism (vs. autonomy). These data suggest areas for future research: for example, on how
providers decide whether, what and how to communicate about these issues, and how these
choices shape treatment decisions.
Keywords
doctor–patient relationship; doctor–patient communication; decision-making; risk and benefits;
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INTRODUCTION
Individuals who have, or are at risk for, BRCA 1/2 mutations and/or breast cancer face
difficult treatment decisions of whether to undergo prophylactic surgeries; but little is
known about how these individuals in fact make these decisions—particularly, what stresses
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they face in making these decisions, and what roles, if any, health care providers and others
may play.
These issues are important since many women who might benefit from prophylactic surgery
do not undergo it. Since ovarian screening is poor, for BRCA mutation carriers, the National
Comprehensive Cancer Network recommends prophylactic ovarian surgery by age 35 or by
the completion of childbearing [National Comprehensive Cancer Network], and bilateral
prophylactic mastectomies for women at high-risk who are interested. Prophylactic
oophorectomies and mastectomies have been found to reduce cancer incidence compared to
chemo prevention or surveillance [Bermejo-Perez et al., 2007]. For mutation carriers,
oophorectomy alone, and oophorectomy with mastectomy have also been found to be the
most cost-effective strategies [Anderson et al., 2006]. Yet rates of these surgeries vary,
depending on country, and other factors. In the US, for example, of asymptomatic women
with BRCA 1/2 mutations, 13% opted for prophylactic mastectomies, and 13% for
oophorectomies [Lerman et al., 2000]; and 27%, along with 5% of non-carriers and 2% of
patients with uninformative results, chose oophorectomies [Schwartz et al., 2003]. However,
a Dutch study found that of asymptomatic women with BRCA 1/2 eligible for prophylactic
surgery, 51% and 64% chose bilateral mastectomies and oophorectomies, respectively
[Meijers-Heijboer et al., 2000]. The reasons for these differences between countries are not
clear [Metcalfe et al., 2008a,b]. All surgeries carry potential complications (e.g., from
anesthesia), that women must balance as well.
In influencing these rates, several sociodemographic and medical factors have been
suggested, particularly BRCA test results, and family cancer history [Ray et al., 2005;
Graves et al., 2007], though certain other factors have received less attention. Age, race, and
having children may affect uptake and timing, as young women with children may opt more
for mastectomies, while older women opt more for oophorectomies [Bradbury et al., 2008].
Psychological factors, particularly perceived risks and benefits and pre-cancer worry, have
also been suggested as affecting intentions [van Dijk et al., 2003] and decisions to undergo
mastectomies and oophorectomies [Antill et al., 2006; Madalinksa et al., 2007], and genetic
testing itself [Helmes, 2002]. Other factors mentioned include trust in the capacity of tests to
reduce morbidity [Kram et al., 2006], and patients being “monitors,” not “blunters” of
information [Miller et al., 2005]. In Canada, rates of surgery vary by region [Metcalfe et al.,
2007], though the reasons for this geographic difference are not clear. Qualitative research
has suggested that women may choose oophorectomies based on additional factors such as
risk perceptions, cancer witnessed in family members, family obligations, concerns about
fertility and menopause, and fear of surgical complications, [Hallowell et al., 2001]. In
general, women must balance potential benefits of anxiety-reduction against potential
complications of surgery [Tiller et al., 2002].
But questions persist concerning the decision-making processes involved—for example—
how women actually approach and balance these various issues and needs, and make these
difficult choices and trade-offs of whether or not to undergo these various preventive
surgeries, and when and how. Though potential factors have been suggested, as above, the
decision-making processes entailed remain unclear. Given that rates of surgery are still
relatively low among younger women for mastectomies, and among older women for
oophorectomies, critical questions persist of how women view and experience these
decisions, and what, if anything, might be done to assist women in making these decisions.
In shaping other medical decisions, relationships with providers and family members have
been found to play critical roles [Klitzman, 2008]. For example, for another genetic disorder,
Huntington Disease, familial contexts can shape experiences of being at risk [Cox and
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McKellin, 1999], and testing, disclosure and reproductive decisions [Klitzman et al.,
2007a,b,c].
We conducted a literature search, and found that only a few studies concerning testing—but
almost none concerning treatment—for BRCA 1/2 have explored interactions with providers.
Several studies on communication about BRCA testing suggested that testing decisions and
understandings of genetic risk operate in dynamic interpersonal relationships and are
subjective [Gifford, 1986]. Most, but not all BRCA mutation carriers have discussed their
results with a doctor or healthcare provider [Botkin et al., 2003].
Patients’ subsequent approaches to treatment as a result of such testing may similarly be
subjective, and be shaped by social contexts, but these phenomena (e.g., interactions
concerning breast cancer treatment) have received relatively little attention. In one of the
only investigations we found that broached this area—a study of African-American women
—carriers were more likely than non-carriers to discuss results with primary care providers
after testing. Yet carriers usually did not communicate with providers about prophylactic
mastectomies and oophorectomies (i.e., only 24% and 43%, respectively, did so) [Kinney et
al., 2006]. Premenopausal women have also reported unmet information needs before and
after procedures [Meiser et al., 2000]. Similarly, though tamoxifen has been suggested as a
possible preventive therapy among mutation-positive women, most women in one study said
that their doctors had not provided them with enough information to consider it [Metcalfe et
al., 2005].
A handful of studies have explored views of providers concerning available treatment
options. For example, more general surgeons than plastic surgeons or gynecologists (85%,
47%, 38%, respectively) thought prophylactic mastectomies had a role in caring for high-
risk patients (P = 0.0001), but only 39% of general surgeons, and 18% of gynecologists ever
recommended it (P < 0.001) [Houn et al., 1995]. Among French doctors in 2000, only
18.7% thought prophylactic mastectomy acceptable for a women with BRCA 1/2 [Julian-
Reynier et al., 2000]. Physician views may affect patients in several ways. For example, in
one study, the most common predictor of regrets post-surgery was discussion having been
initiated by the provider, rather than by the patient [Payne et al., 2000].
Though studies suggest that enhanced genetic counseling can help with decision-making
[Miller et al., 2005], there is a shortage of genetic counselors. The US has only about 2,000
genetic counselors, not all of whom are practicing at any one time [American Board of
Genetic Counseling, 2008]. Decision-making aids have been developed for patients
[Kaufman et al., 2003; Lobb et al., 2006], but it is not clear how these do or might actually
alter interactions. Similarly, given the many psychological factors involved, it has been
suggested that counseling psychologists become involved in helping patients with these
issues [Kaut, 2006]. But the roles that physicians actually now play remains uncertain.
From a theoretical perspective, in research thus far on patient decision-making related to
genetics, cognitive models have predominated. For example, the Health Belief Model
suggests that an individual’s health behaviors are shaped by perceived susceptibility, disease
severity, and costs and benefits of the behavior [Rosenstock et al., 1988]. The Stages of
Change Model [Prochaska et al., 1992] suggests that individuals proceed from being
unaware, to aware but unengaged, to engaged in a health decision.
But in both of these theoretical models, it is not clear whether providers and others influence
these factors or stages, and if so, when, how and to what degree. Providers might potentially
affect such awareness and beliefs, but it is not clear if they in fact do so, and if so, how.
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Thus, we decided to explore how exactly women experience and make these difficult
decisions regarding prophylactic surgery for breast and ovarian cancer: what stresses they
face in the process, whether social contexts with providers and others affect these decisions,
and if so, how.
METHODS
Sample
To understand most fully the range of issues and experiences that women at risk of breast
cancer face concerning prophylactic surgery, and the roles and implications of these issues
in these women’s lives, we recruited women who differed in both testing status and
symptom status. Thus, we included women who were both symptomatic and asymptomatic,
and both tested and untested. Among those who were tested, we included both those who
had and those who did not have a mutation. To recruit participants, we distributed
information about the study through breast cancer clinics, other breast cancer studies at our
institution, a newsletter to a breast cancer family registry, flyers displayed on bulletin boards
of our institution, and word of mouth. Individuals contacted the principal investigator if they
were interested. As revealed in their narratives, many of these women had over time
occupied more than one of these categories. For instance, all tested women were initially
untested, and all symptomatic women had initially been asymptomatic. Interviewees all
discussed both their past and present views and experiences regarding these issues. We
included women who were able to give consent and spoke English. As indicated in Table I,
we interviewed, for 2 hr each, a total of 32 women, including 20 who have had breast and/or
ovarian cancer, and 12 who have not; and 19 of whom have had BRCA 1/2 testing (8
mutation-positive, 10 mutation-negative and 1 indeterminate result). Of the symptomatic
women, 14 were tested (7 BRCA 1/2 positive, and 7 mutation negative).
With each participant, the PI conducted a confidential in-depth semi-structured interview
concerning experiences of having, or being at risk for breast cancer. Interviews were
conducted in the PI’s office and took approximately 2 hr, though varying somewhat in
length. The Columbia University Department of Psychiatry Institutional Review Board
approved the study, and all participants gave informed consent. Relevant sample questions
from the semi-structured interview guide are attached (see Table II), through which we
sought to obtain detailed descriptions of the process of individuals’ view and decisions
concerning testing treatment and related issues.
On theoretical grounds, Geertz [1973] has advocated studying aspects of individuals’ lives
and social situations not by imposing external theoretical structures, but by trying to
understand individuals’ own experiences, drawing on their own words and perspectives to
obtain a “thick description.” Hence, to understand most fully the range of factors and issues
that may be involved in genetic testing decisions, we used qualitative methods.
Data Analysis
We have adapted elements from Grounded Theory, as described by Strauss and Corbin
[1990], because we were interested in understanding a complex social process. Specifically,
grounded theory involves both deductive and inductive thinking, building inductively from
the data to an understanding of themes and patterns within the data, and deductively drawing
on frameworks from previous research and theories. For example, interviewees introduced
topics such as interactions with providers that were then explored further in these and other
interviews. Our approach was informed constant comparison in which data from different
individuals were compared for similarities and differences to see whether these suggested
hypotheses. Transcriptions and initial analyses of interviews were done during the period in
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which the interviews were being conducted and helped guide the interviews. Interviews
were conducted until “saturation” was reached (i.e., “the point at which no new information
or themes are observed in the data”) [Strauss and Corbin, 1990; Guest et al., 2006].
Once the full set of interviews was completed, subsequent analyses were conducted in two
phases, primarily by the PI together with a research assistant (RA) who had social science
training. In phase I of the coding, the PI and the RA independently examined a subset of
interviews to assess factors that shaped participants’ experiences, identifying categories of
recurrent themes and issues that were subsequently given codes. These two coders assessed
similarities and differences between participants, examining themes and categories that
emerged, ranges of variation within categories, and variables that may be involved. The
coders systematically coded blocks of test to assign “core” codes or categories. While
reading the interviews, a topic name (code) was inserted beside each excerpt of the interview
to indicate the themes being discussed. The coders then worked together to reconcile their
independently developed coding schemes into a single scheme, developing a coding manual
and examining areas of disagreement until reaching consensus between them. New themes
that did not fit into the original coding framework were discussed, and modifications were
made in the manual when deemed appropriate.
In the next phase of the analysis, we subdivided thematic categories into secondary or
subcodes, and then refined and merged these, when suggested by associations or overlap in
the data. Codes and subcodes were then used in analysis of all of the interviews. Major
codes included, for example, occasions when providers offered input to patients concerning
surgery. Subcodes were conceptual and thematic subdivisions of these larger categories and
included reactions and behaviors of patients (e.g., patients’ responses to input from
physicians). To ensure coding reliability, these two coders analyzed all interviews. We
examined any areas of disagreement until consensus was reached. To further enhance
trustworthiness, we compared themes in the data with existing literature concerning breast
cancer and other genetically associated diseases, as discussed above. These data also
appeared to have a certain “face validity”—that is, they seemed to be consistent with clinical
experiences and previous research in this and related areas. We have presented below text
from the interviews to allow readers to judge these data for themselves as well.
Management recommendations for risk-reducing mastectomies and oophorectomies differ.
Yet clinical guidelines for both leave much room for questions for women. For
oophorectomies, women have to decide exactly how long before turning age 35 they can
wait before undergoing surgery. Prophylactic mastectomy decisions pose difficult choices as
well, weighing risks of disease versus risks of surgery; and balancing desires to avoid each
set of potential dangers. Hence, though the issues vary in some regards, we found that in
contemplating each type of surgery, common themes often arose, as described below.
Women faced critical similarities: in both instances confronting troubling dilemmas, having
to weigh conflicting psychological desires, and encountering similar patterns of challenges
in communicating with providers and others. Differences emerged as well, as we have
indicated, but overall, the similarities appeared to far outweigh the differences.
Moreover, many women faced decisions concerning both of these prophylactic operations as
well as surgery for treatment—either simultaneously or sequentially. Women’s experiences
confronting one procedure often thus shaped their subsequent decisions concerning other
operations. Hence, we have decided to present together the issues that these surgeries pose,
rather than isolating and presenting issues concerning just one prophylactic procedure, out of
context from the other.
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Overall, as shown in Figure 1, in these decisions, women confronted, and struggled with,
several sets of uncertainties that generated difficult stresses. They wrestled with a sequential
series of agonizing treatment decisions—for example, whether to undergo these treatments,
and if so, which, when and how. As a result, they sought and received input from providers,
family members, friends and the breast cancer community. These stresses and subsequent
interactions could potentially shape patients’ ultimate treatment decisions. Yet complexities
arose concerning this communication. As indicated below, interviewees discussed their own
experiences as well as those of family members (e.g., sisters) and friends in confronting
these issues. Passages of text from the interviews, below, illustrate these issues, often
highlighting simultaneously more than one theme (e.g., as a patient communicates with a
doctor about a treatment decision), as described.
SERIES OF STRESSFUL QUESTIONS FACED
Whether to Undergo Surgery
As shown in Figure 1, in making these decisions, women faced a series of questions,
involving stressful uncertainties of: whether to undergo genetic testing, whether they would
develop cancer if they had the BRCA 1/2 mutation or not; and whether to undergo a
lumpectomy or mastectomy, prophylactic mastectomies, breast reconstruction, and/or
oophorectomies.
Dilemmas of whether or not to undergo surgery are exacerbated by the fact that prognoses
are uncertain both with and without surgery; and operations can have unpredictable side
effects. Hence, initially, when becoming aware of the notion of prophylactic surgery, many
women were wary.
Many considered or pursued testing precisely because it would give them the option of
contemplating prophylactic surgery if they were to test mutation-positive. Some tested to
know if they should undergo prophylactic surgery. Others avoided testing because of
treatment imperatives they would then have to face. One woman, a professor, described how
views about eventual prophylactic surgery arose during initial testing decisions.
So far, I have opted to not get tested. It’s an open question. I asked my oncologist,
“What difference would it make in my treatment?” She said, “At some point I
would say: take out your ovaries, if there were a genetic link.” So, do I want to
have my ovaries taken out, having been genetically tested? Or, do it
prophylactically even without the testing? BC7
She poses a series of questions with which she still wrestles. She continued, about her
support group,
Most of us have not been tested. Other perspectives are: I want to know if I’m
going to get it again, if I should have my ovaries out, or have a prophylactic
mastectomy. BC7
Even some who decided not to undergo testing, nonetheless considered prophylactic
surgery.
Of note, some subjects whom many physicians may not consider to be appropriate for
testing were nevertheless tested by their providers, suggesting that testing may occur
anyway in various cases. These individuals tested because they “just wanted to know,” and/
or their insurance would cover it since they had already had cancer, and they felt that the
information might be helpful to their adult offspring who had not yet had cancer. These
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offspring could face stigma and discrimination, if tested themselves and found to have a
mutation. In addition, it is possible that some providers may not fully understand when
testing is versus is not indicated.
Which Surgeries to Undergo
As described elsewhere here, women faced decisions about whether to undergo a series of
surgeries—prophylactic mastectomies (possibly followed by reconstruction), and
oophorectomies, in addition to operations to remove existing lesions—for example,
lumpectomies and mastectomies.
When to Undergo Surgeries
Uncertainties arise, too, of when to undergo surgery—weighing desires to delay in order to
become comfortable psychologically with the possibility versus desires to eliminate cancer
worries and needs to stop possible disease progression as soon as possible. Particular
questions surface of how long they could wait, after having a mastectomy, before
undergoing oophorectomies, without deleterious consequences.
I’m pretty much certain that I’ll have my ovaries removed … My oncologist said I
don’t have to have it done now. They’re suggesting: before I’m 50. I’m 40. Could I
wait 10 years? As I get older, the incidence of ovarian cancer increases. I’m not
sure if I’m eliminating any unnecessary anxiety by doing it sooner rather than later.
But, being through what I’ve been through this year, I feel that if I were to do it
now, I could at least put this chapter in my life behind me in some way, and not
worry. I’m concerned with getting a cancer they can’t detect. And I don’t want to
be under the magnifying glass the rest of my life. I have these mixed feelings about
it: real confusions in my mind about what to do. BC6
These women experience these decisions in the context of their on-going risk and/or illness
over time, adding stress since each decision occurs as part of a langer sequential series of
choices. Hence, many sought to postpone decisions, though doing so can represent, in part,
denial as a way of coping with the stresses involved. As another woman, who had bilateral
mastectomies and was now contemplating an oophorectomy, said,
I don’t want to think about it. I picked a number: when I hit 45. Next year. I guess I
haven’t decided. I mean, I’ve decided, but I keep on putting it off. For doctors, it’s
an easy decision. They say: “take it out right away.” That’s fine, but for me, it’s
like: “Can’t I just wait? I’ve gone through enough.” I understand it’s increased my
chances of getting ovarian by 40% over a woman’s lifetime. BC4
She distinguishes physicians’ cavalier stances about these procedures from her own
hesitation due to her history of illness, including a mastectomy. This past operation thus
frames her outlook toward a possible oophorectomy. Given these difficult tradeoffs, though
she understands the medical risks, she tries to delay surgery, thinking of excuses.
I wanted to wait a year after surgery. Then, “I’ll wait until I go into menopause.”
Well, now I’m there. I’m going to constantly give an excuse. BC4
She suggests a psychological process, involving a series of rationalizations, which can serve
continually to delay the operation.
What Side Effects May Result From Surgery
Women face ambiguities, too, about the possible deleterious effects of surgery—including
subjective concerns of whether it will harm physical attractiveness, sexual experiences and
relationships, and views of one’s body or of oneself. To answer these questions definitively
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is hard. One woman, with a strong family history that included a sister, was very anxious
about her risk, though she had not yet decided to undergo testing. She said,
Over the last few weeks, I’ve been looking at other women’s breasts, thinking, “Is
it really that big a deal?” wondering what some of the sensations are going to be
like. Arousal in your nipples is not going to be there. But how much does that
interfere with having a loving and caring intimate relationship? BC15
Uncertainties arise about the effects of these on both sexual experiences, and romantic
relationships.
Communication About Stresses
Given these quandaries, women generally sought and received input from several groups of
others, including health care workers (HCWs), friends and family, and breast cancer
communities. As shown in Figure 1, issues arose concerning several aspects of
communication from each of these groups—factors that shaped both how assistance was
offered and received.
Communication With Doctors
What doctors communicate—HCWs offered input, though these interactions often
proved complicated. The uncertainties discussed above led many women to want clear,
unambiguous medical opinions. Given the complexities and subjectiveness of decisions
about prophylactic surgery, many physicians and other individuals did not feel comfortable
giving such unequivocal input. The very personal aspects of these stresses made many
providers and others hesitate or feel unable to offer clear advice. As one woman, who faced
decisions of whether to undergo a lumpectomy versus a mastectomy, said:
I called my internist, because she’s a good friend, to help me make that decision.
But she just felt she really couldn’t. BC23
Physicians may feel torn—wanting to help patients, but recognizing that in the long run,
giving a simple definitive opinion may not be best.
Patients may recognize that such certain input may ultimately be elusive. She continued:
Sometimes we want to hear that there is one answer, but there is none. Sometimes I
wished somebody said, “This is how you do it. If you have Strep throat, this is the
pill. That’s it. End of story.” Whereas with this, you have to make a judgment call.
A lot of information comes at you fast and furious. Sometimes it’s a lot easier just
being a little kid: Your mother says this is what you’re having for dinner, instead of
you having to go to the supermarket and decide. BC23
She underscores the stress and difficulty of having to confront these dilemmas, and assess
relatively large amounts of information without sufficient guidance, while desiring certainty,
which may not be possible.
Clearly, differences can emerge when surgeons work with newly diagnosed women with
cancer (where direct approaches may be well-suited) versus women contemplating
prophylactic operations (where non-directive discussions may be more appropriate). Yet this
woman suggests how ambiguities arise even for this decision between lumpectomy versus
mastectomy, which may involve both therapeutic and prophylactic considerations.
Doctors may vary in not only how directly they make their recommendations, but also in
whether they present other treatment options. Given the exquisite sensitivities involved,
with threats to the body and with the symbolic meanings of breasts and ovaries, women
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frequently wanted at least to hear about possible alternatives, and to have these options
addressed as sensitively as possible. Yet, these patients often felt disappointed.
I left the first breast surgeon because he said, “Ok, here’s what we do: we’re going
to remove your breast, and you’re going to have chemotherapy and potentially
radiation.” My husband and I sat there saying, “We don’t need it sugarcoated, but
what about alternatives?” He said, “You could pursue these, but …” In the end, I
ended up doing what that doctor said, but with a breast surgeon who worked with
my Integrated Medicine Oncologist—they had worked together before, and
respected each other. BC6
This first doctor ignored a holistic approach and complementary and alternative medicine
(CAM) that the patient valued. As she explained,
I’ve been working with an Integrated Medicine Oncologist, and the belief system
with an Integrated Medicine Oncologist is very different than with a traditional and
conventional doctor. Part of my protocol, besides doing the conventional stuff, has
been to integrate meditation, acupuncture, massage therapy for stress reduction,
lymphatic massage, and a variety of supplements, not just vitamins, but
antioxidants and extra Vitamin C, algae and very large doses of dehydrated
vegetables and fruits.
Many women felt that such alternative adjunct therapy was important, even if doctors
dismissed it. Nonetheless, a physician’s presentation of, or openness to, such alternatives
may enhance patients’ satisfaction and trust.
How doctors communicate—Clearly, physicians varied in the degrees to which they
provided input versus left the decision up to the patient. Physicians may not answer what to
do, due to the uncertainties and subjectivities involved, and instead leave much of the
decision-making up to the woman herself—including choices among surgical options (e.g.,
lumpectomy vs. mastectomy). Yet these difficult options can overwhelm patients.
The doctor said there might be something in my nodes, so it was my choice to have
the breast removed or leave it. After I found out I had breast cancer, I decided to
have it removed. It was very hard—like the world was coming down on me. BC21
These decisions can thus feel onerous—even crushing.
On the other hand, in the face of these uncertainties and sensitivities, some physicians may
provide input too readily or forcefully. Particularly for oophorectomies, given their
considerable reproductive and psychological implications, doctors can appear insensitive
regarding the stresses involved, not seeing these issues from patients’ points of view.
Doctors varied in not only the content and directiveness of their input, but their tone and
sensitivity. These concerns arose for surgery as both treatment and prophylaxis.
For doctors, it’s just another day at the office. They don’t consider the patient, and
what she is going through. When my sister was getting the mass removed from her
ovary, the doctor said, “We’ll go in, scoop it out. We’ll be out in a minute.” Scoop
it out? It drove me insane. He was “one of the best”, but I feel so bad for any
woman who goes to him. I’ve seen other doctors like that, too, male and female, it
didn’t matter. BC1
Relatedly, doctors may appear insensitive not only in what information they presented—but
where (in what context) they presented it. As one woman said about an ultrasound that
found ovarian cysts,
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This doctor tried to discuss with me the results of the sonogram over the phone. I
said, “Hi, doctor,” and suddenly I’m being told about this stuff. I didn’t want to
hear it over the phone. I don’t think she was a good doctor. I don’t see her
anymore. My experience was bad. BC25
The information provided by this doctor may be scientifically valid, but the patient did not
like how it was conveyed—specifically, the context—both over the phone, and without
emotionally sensitive framing of the information (i.e., without any introduction to
contextualize the information in order to try to lessen the trauma). Such perceived
insensitivity can be unexpected and surprising, coming from a relatively young female
physician. Such patient reactions, though subjective, are nonetheless important, potentially
shaping patient satisfaction, trust, and treatment adherence—and thereby treatment
outcomes. Of note, here, too, the gender of the physicians did not seem to matter.
When doctors communicate—Given these vagaries, doctors’ timeframes also differed
in both raising the topic of surgeries, and recommending that patients undergo these
procedures. Physicians ranged in the degrees to which they raised time considerations (e.g.,
pushed patients in these decisions). Some patients felt urgency from doctors to undergo
surgery, and perceived insensitivities concerning the time dimensions involved.
My gynecologist and oncologist are ok with waiting. My breast doctor is the only
one pressuring me. BC4
The fact that this patient felt pressure is important, as it suggests possible elements of
coerciveness that could restrain a patient’s feelings of autonomy. Questions emerge, too, of
tensions physicians may confront between autonomy versus paternalism (i.e., doctors
encouraging what they think is best).
HCWs may face conflicts, too, in deciding when initially to raise options of surgery, in order
to allow patients to prepare psychologically as much as possible. The possibility of
prophylactic surgery emerges not only after genetic testing is conducted, but beforehand as
well, when considering genetic testing itself—as a hypothetical. Yet women may see
providers as presenting options either too early (e.g., before women undergo genetic testing)
or too late. HCWs may want to prepare patients for the possibility of surgery by raising the
topic before genetic test or biopsy results are available. Yet women may feel that these
conversations then occur prematurely.
Before I got my test results, the doctor jumped ahead to tell me: if you’re positive,
you should just take out your ovaries. I wasn’t sure. I didn’t think I wanted kids.
She said, “Then it’s easy. You’ll just take the ovaries out.” She seemed very
confident. I thought, “What?! You don’t even know what I have! Why are you
telling me that?” BC25
A patient may think about these questions and objections, but not feel comfortable
expressing them to a provider. This discomfort could thus impede patients in giving
feedback that might otherwise prompt doctors to communicate further and clarify treatment
rationales. Thus, physicians may need to be careful in framing their input, explaining their
reasons for broaching these topics—for example, not to cause anxiety prematurely, but to
prepare patients by discussing the options as much in advance as possible.
Why doctors communicate as they do—Patients suspected that at times, institutional
factors hampered provider communication. Some patients felt, for example, that providers
may defer from being more involved in these decisions in part because of legal liabilities
and/or insurance concerns.
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If they say, “this is what you do”, and things backfire, somebody’s going to turn
around and sue. No doctor wants to take that legal risk. BC23
Hence, patients at times felt that doctors may not discuss certain options unless patients
specifically asked about these.
The doctor recommended a mastectomy only on the sick breast. I asked, “How
about this other one? Do I run the risk of developing something there?” The doctor
said, “Yes, it’s a good idea. I’m glad you asked: I’m not allowed to raise it by
myself.” She couldn’t recommend it without me asking for it. BC28
This patient felt that insurance or other constraints may limit the doctor’s options, though in
this particular instance, the precise nature of these constraints was not wholly clear.
Nonetheless, this woman highlights how patients felt that the larger health care system could
at times restrain physicians.
Other factors may play roles here as well. Doctors’ personalities may prove important, yet as
suggested earlier, physician age and gender may not always predict sensitivity toward these
issues. As mentioned above, a physician may act insensitively despite being young and
female.
Implications
As a result of physicians’ low levels of input, finding the “right” physician can be hard,
further exacerbating stresses. As a result, women may “shop around” for a doctor they like,
though they did not all have flexible insurance plans or out-of-pocket funds to allow them to
do so. Difficult tradeoffs thus arose in choosing doctors. Even with a lumpectomy, questions
emerged as to how extensive an operation to have. As one patient, who was a lawyer, said,
I went to four different surgeons. My parents and partner felt that the first one
would be too busy. Another was too paternalistic. A third one wanted to take out a
bunch of nodes, rather than do a sentinel node biopsy, so I eliminated her, though I
liked her a lot. BC7
Women have to consider what a doctor recommends, as well as how and when he or she
recommends it. This woman balanced one physician’s bedside manner versus treatment
recommendation, and weighed the former over the latter. Variations in physicians’ styles,
timing and recommendations thus complicate these choices. Women, in turn, vary widely in
weighing these diverse factors, making it difficult for providers to know a priori how best to
approach these issues with each individual patient. This woman suggests, too, the degree to
which such “shopping” may occur. In her case, she assessed four physicians.
Communication With Family and Friends
Given these stresses and often disappointing interactions with providers, women frequently
turn to others—especially, initially, family members and friends. Yet these additional
interactions, too, range considerably.
How family and friends communicate—Family members and friends can differ, as do
HCWs, in being either too aggressive and “opinionated” or too removed. One woman felt
pressured by her employer.
My boss always pushes me to get the surgery. She has Multiple Sclerosis. Living
with her situation, unable to do anything about it, she thinks, “are you crazy? You
can do something! Do the surgery. And don’t have the reconstruction—do it the
simple way.” But I just don’t think I can deal with a double mastectomy, seeing
what it looks like. BC8
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These highly personal and subjective issues can lead women and their close social supports
to vary in viewing these choices. Ultimately, this patient underwent an oophorectomy, but
not a mastectomy, choosing one type of prophylactic surgery, but not another. She
illustrates, too, how patients confront, and receive input regarding not simply one isolated
decision, but several linked ones—here, of mastectomy and reconstruction.
Whether they agree or disagree—A patient’s main social supports can agree or
disagree with each other and/or the patient, creating conflicts that the patient must then
address, balancing these competing views. As one woman said about a possible
oophorectomy,
My siblings are leaning towards “no: why have surgery when you might not need
it?” My friends are leaning towards “yes: cancer is bad. If you can lower your
chances, why not?” BC27
Patients must then weigh such clashing arguments against each other, negotiating between
these views, and the proponents of each. Patients may remain undecided what to do.
Other individuals can prove vital in bolstering a woman’s own preference, and deferring to
it. For instance, a strong relationship, and support from a partner can help minimize
surgery’s possible impediments (e.g., to a woman’s romantic life).
My partner’s mother and sisters had breast cancer. His mother had a radical
mastectomy. He had melanoma, and his second son had leukemia. My doc asked
my partner, “What do you think about it?” He said, “She’s going to have bilateral
mastectomies. I’m not going to stand in front of this freight train.” BC15
He respected and valued her autonomy, in part due to his own experiences and those of his
immediate family members—all of which then made it easier for her. Thus, these
interactions can be highly dynamic; and a spouse’s or other family members’ own past
personal experiences can in turn shape a patient’s experiences as well.
Other women may not be as fortunate to have as reinforcing and knowledgeable a
significant other, though in the end, families and close friends generally upheld, rather than
opposed patients’ preferences. Spouses, in particular, usually saw their opinions as
secondary to the patient’s own. Family and friends may voice strong opposition but, in the
end, respect, more than do physicians, a “feminist” position—that ultimately, a women’s
decisions about her body are her own.
In the end, despite the fact that my boyfriend was so against it, and people said,
“Oh my God, it’s so drastic,” it was my decision. It’s my life. Nobody else’s. A
guy’s perspective is irrelevant—purely sexual, or selfish. Basically, this has
nothing to do with him, and everything to do with me. If any woman is thinking
about what a guy is thinking, she’s foolish. Ultimately, it’s her life. BC14
Communication With the Breast Cancer Community
Given these stresses and often suboptimal inputs from providers and, potentially, family
members and friends, many women also turned for assistance to communities of other
women confronting breast cancer. These communities—both formal and informal—could
fill in gaps left by families and providers. Yet, several sets of issues arose here, too.
What communities communicate—Within breast cancer communities, women vary in
what information they share and how they do so. Debates about these surgeries occupy
much on-line communication, and information from websites and patient advocacy
organizations (either on-line or through support groups or meetings) can aid these decisions.
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One woman, for example, had undergone an oophorectomy, but has had difficulty facing the
prospect of additional surgery—a mastectomy.
On-line, the biggest issues are whether to be tested or not, and have surgery, once
you know you have this gene. Some women are really pro-surgery, and have done
everything possible. Others feel they don’t need to go to such extremes. Women
who haven’t had cancer, but have mothers or sisters who have, go to extremes and
have preventive surgeries. I give them a lot of credit; that’s very brave. I haven’t
been able to come to terms with surgery. BC8
Hearing about others’ decisions can be helpful, though women saw themselves as varying
widely in key factors such as tolerance and acceptance of risk. Patients can take strong
positions (e.g., being “pro-surgery”) and do what others may consider “extreme.”
Nonetheless, these interviewees generally felt that ultimately, individuals do and should
weigh these choices based on their own courage and personal concerns.
Individuals in communities can vary and clash in their opinions, and potentially sway each
others’ decisions. One woman with a strong family history spoke to other women when
initially considering testing and its implications. She had contemplated the possibility of
prophylactic surgery as a reason to undergo testing.
Other women have had double mastectomies—because their mothers died early—
and feel it saved their lives. For them, it made sense; so I did hear some positive
stories to counter this insane invasive surgery. BC25
This woman decided to pursue testing, and turned out to be mutation-negative.
The specific venue can affect these parameters. For example, the Internet offers certain
advantages over direct face-to-face interactions, providing large amounts of information
(including, importantly, photographs of surgical results), and permitting anonymity. Within
these communities, members can share intimate experiences and even images of breasts
after surgery. Frequently, norms prevail that prioritized such sharing, altruism and
communitarianism over protection of personal confidentiality. This communality forges and
in turn further strengthens social connections. Women may not even see options to such
sharing.
If someone asks me, I’d probably show her my breasts. How great they look … I
show everybody who wants to look. I’m not shy. How can you be? BC14
The breast cancer community served critical functions, providing key information that
physicians and often family and other friends did not. Patients frequently sought as much
information as possible, and hence valued the vast amount of data and experience, both
visual and verbal, available on-line. A strong sense of community exists even on-line,
encouraging and facilitating patients in helping each other. Nevertheless, patients ranged in
the degrees to which they were willing to forego confidentiality in exchange for additional
social support.
Women differed, too, in the amounts and kinds of information they sought. Some women
were “highly proactive,” looking at outcomes even before receiving their own genetic test
results, in order to help decide what prophylactic or other surgeries to undergo. Patients may
even shop on-line for surgeons before receiving their genetic test results. Even before
testing, one woman said,
I went to some of the big plastic surgery sites. You can go through lists of hundreds
of surgeons, and look at their patients’ pictures before and after. I looked at the
pictures of people who had had prophylactic work done vs. mastectomies only after
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developing cancer. The prophylactic ones looked a hell of a lot better. I even
looked at the different techniques. I was thinking the flap would be good. BC26
She wanted to see other women’s results herself—highlighting the importance of visual, not
only verbal information in confronting these multiple uncertainties.
Someone might say, “Why not ask your doctors for recommendations?” But I
wanted to see what kind of work they do—what reconstructed boobies looked like
in both cases, if there was a difference. You had more choices if you did it sooner
—making it look better. BC26
How to assess information—As suggested above, women have to assess the content
and validity of information they receive, which can be difficult. Within these disease
communities, patients have to judge each others’ views in the contexts of possible biases,
personal preferences and personalities. Patients varied in how much to accept versus
question information accessed—particularly on-line from anonymous sources.
How involved to be—Women faced as well dilemmas of how much, and in what ways to
participate in these communities. Not all women entered these groups (thereby giving and
receiving information) to equal degrees. Within these social contexts, the experiences of
others who had undergone surgeries can be helpful and/or frightening. Women may become
very involved, seeking much information to help in making decisions. They read about, and
reflect on, other women’s choices. Patients may benefit from this input initially, or at later
stages of their diagnosis, and become less involved at other times. These communities could
expose women to patients with more advanced illness, which can potentially be upsetting,
though the women here generally appeared able to modulate their degree and type of
involvement to remain comfortable with it.
Several patients became very active in these disease communities, with these involvements
coming to structure much of their lives; yet these engagements, while helpful, can prompt
criticism from others. Family members and friends may feel that these activities take too
much time. One woman’s relatives did not understand the benefits she received from
participating, and they chastised her instead to “get a life.”
DISCUSSION
These data elucidate the series of questions that women face, involving stresses and
uncertainties, when confronting the possibilities of prophylactic surgeries for breast and
ovarian cancer, and the difficulties that women confront in communicating about these
dilemmas with providers, family and friends, and breast cancer communities. Women
encounter questions of whether to undergo surgery, how to assess uncertain prognoses
related to genetic tests and surgery, which surgeries to undergo (e.g., prophylactic
mastectomy, reconstruction, and prophylactic oophorectomy), when to undergo these
operations (i.e., now vs. delaying); what side effects may result (e.g., harm to physical
attractiveness, sexual experience/functioning, romantic life, and views of one’s body and
self), and how to decide (e.g., whether to accept or reject input from HCWs and others).
These issues concerning prophylactic surgeries could even shape decisions of whether or not
to undergo genetic testing.
These dilemmas lead many women to seek guidance from doctors and others who appeared
then to vary in what and how they communicated about these issues. These potential social
supports ranged widely, and often defer from offering strong input for several reasons.
These decisions involve deeply personal and hence subjective values. Ambiguities are
inherent in risks of both surgery and future cancer. Providers may also be constrained by
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limitations of the health care system, related to insurance or liability concerns. While some
women felt disappointed that a physician was not more directive, others rejected doctors’
input as too forceful or definitive, and hence insensitive.
Given, in part, that interactions with providers may not be wholly satisfying, women often
turn, too, to family members and friends. Yet these social supports can also range widely in
how and what they communicate, and whether they agree or disagree with the patient and/or
each other. Input from these non-physicians may not be supported by clinical expertise, and
patients may face stresses in deciding whether or not to agree with, and/or follow, these
social supports. In the end, family members and friends may buttress and accommodate
these women’s own choices more than physicians do. Yet tensions could nonetheless arise.
Many women felt dissatisfied with the input they received from family and friends. Yet
these social supports may also feel frustrated, caught in a double bind, being unable to offer
more definitive advice—wanting, but feeling unable to do so.
Given needs that are not otherwise met, many women turn, too, to breast cancer
communities. But women then have to decide how involved to be, what information to
provide or access, and how much to accept or question the information they obtain.
Though factors have previously been suggested (e.g., genetic test results, and family history)
that can affect decisions to undergo surgery, the present data suggest that these
considerations can in fact be highly complex, embodying uncertainties that are difficult
resolve, involving stresses that women struggle to understand and weigh, and that can
impede and/or delay decisions.
These data have several implications for enhancing provider education and doctor–patient
interactions, suggesting how many providers can potentially improve what, how, when and
where they communicate with patients about these areas. Physicians may need to be more
sensitive to these issues, and be prepared to be able broach these areas, related to sexual
functioning, reproductive plans and physical attractiveness, to help patients with these
decisions, acknowledging these subjective and taboo-enshrouded concerns legitimate.
Providers may also need to be more aware of the fact that they may view the form and
content of their recommendations and patterns of communication far differently than do
their patients.
Yet these findings pose inherent challenges as well. Though genetic counselors are trained
to be non-directive, medical education has a long tradition of relative directiveness and
paternalism. Generally, doctors are trained to be more directive, which may help mold these
subsequent interactions. Hence, physicians may need be more aware of their multifaceted
roles, and gauge sensitively each patient’s desires (i.e., for information and paternalism vs.
autonomy), rather than adopt a generic “one size fits all” approach.
But obstacles exist to increasing doctors’ relative non-directiveness. Medical educators may
need to develop models to teach students how to be less directive, and when and to what
degree to do so. Such questions need to be carefully considered and addressed. Concretely,
the present data offer several possible suggestions. For example, physicians should at least
consider discussing treatment alternatives with patients, even if then advising against these.
Asking patients about their informational or other needs and experiences about these
decisions can also be important. At times, it may be helpful for providers, friends and others
who feel in a bind to discuss this predicament with patients (i.e., that failure to provide
unequivocal input reflects not a lack wanting to do so, but inability to do so, due to these
subjective ambiguities).
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Many women are understandably proactive, and think about possible eventual prophylactic
surgeries even as they confront earlier testing and/or treatment decisions. Consequently,
surgeons may need to be prepared to communicate with women about surgeries for not only
treatment, but prophylaxis as well, and thus be ready and comfortable confronting the
complexities and sensitivities involved.
Problems with communication found in these data reflect more general communication
problems in health care [Klitzman, 2008]. However, at the same time, these data also
highlight several specific and unique aspects of these decisions. Prophylactic surgery raises
particular anxieties because the risks of both having surgery and not having it are
considerable, yet abstract and hypothetical, and involve taboo issues concerning sexual
organs, sexuality and physical attractiveness. Physicians often have difficulty discussing
these areas fully and openly with patients [Klitzman, 2008]. In addition, physicians often
have low understandings of genetics [Suther Menasha et al., 2000; Chase et al., 2002;
Schroy et al., 2002; Barrison et al., 2003; Freedman et al., 2003; Baars et al., 2005; Burke et
al., 2006]. Thus, medical education may benefit from addressing these areas more fully.
These data have implications as well for research—to address how to help patients
understand these uncertainties and questions. In part, clinical studies are required to clarify
how long women can wait before undergoing oophorectomies. Yet studies can also explore
how providers, patients, family members, friends and others approach these ambiguities, and
differ in doing so. Individuals may vary in either too readily seeking to minimize such
ambiguity, or taking aggressive stances despite it, which may be perceived by others as
callousness. Future research can help clarify these variations, and factors that may be
associated with these. For instance, one factor, toleration of ambiguity, has recently received
some attention [Geller et al., 1993], and has been found to be associated with physician
socio-demographics (e.g., specialty, age, and race), hypothetical questions about genetic
testing, and certain clinical decisions [Tubbs et al., 2006]. Yet many aspects of medical and
surgical decision-making remain relatively unexamined (e.g., regarding relationships and
types and patterns of communications). Physicians may be better trained in objective than in
subjective considerations, but need to handle both.
More research can help clarify what factors predict what, how and when providers
communicate with patients about these issues, and with what results. While much research
has examined aspects of doctor–patient communication in a binary way (i.e., as present or
absent), these data suggest the multiple complexities involved, related to not just whether
doctors communicate information or not, but what, when, how and why they do so. While
physicians may see themselves as simply “conveying the facts,” the data here highlight the
complex inter-related dynamic issues entailed. Future research can assess the degrees to
which physicians appreciate these issues and needs for flexibility, and vary their approaches
between patients. The degrees to which patients’ and providers’ respective perceptions of
their mutual interactions may predict patient treatment decisions and outcomes can also be
assessed. Given shortages of genetic counselors, doctors may benefit from becoming more
involved in these communications, but may need to change their approaches. Questions
remain, however, of how providers should best assess individual patients’ concerns and
preferences, and convey the complexities involved, what kind of language and approaches
doctors do and should use—for example, to reflect not just paternalism versus non-
directiveness, but more in-between, nuanced, and flexible models.
It is unclear, too, how physicians do and should interface with other sets of patients’ social
inputs—whether physicians ever do or should refer patients to on-line sites, and if so, which
when, why, and with what results. Research is needed as well on how exactly women decide
how involved to be in breast cancer communities, and what information they seek
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concerning these and other decisions, how these communities affect these choices, what
relevant information various on-line breast cancer communities and websites provide, and
how accurate and unbiased it is. Commercial medical sites focused on other diseases have
been found often to be biased—presenting benefits of interventions far more than risks
[Klitzman et al., 2009]. In on-line breast cancer support groups, active participation has been
found to be associated with being white, having a higher energy level, and having a more
positive relation with one’s physician [Shaw et al., 2006]. For several diseases, studies of the
content of on-line communities have found that most messages involved informational and
emotional support [Coulson et al., 2007]. Breast cancer websites may decrease the medical
profession’s “information monopoly” [Radin, 2006]. For fibromyalgia, one on-line support
group was found to challenge physician expertise [Barker, 2008]. For prophylactic surgery
for breast and ovarian cancer, whether biases or inaccuracies or distrust of physicians exist,
and if so, how often, and in what ways remain unknown. Particular groups or sites may
demonstrate biases one way or the other. For example, dissatisfied patients more than others
may express their opinions. Future research can examine these issues as well. Similarly,
future studies can explore how often women may seek on-line information either to support
their own prior preferences, or find new information that may alter their prior attitudes. Such
research can assess which women seek which type of information, and with what results.
Questions arise, too, as to how to enable breast cancer communities and providers to work
best together.
These data also suggest needs to investigate more fully how, and to what degrees the
difficulties in communication described here may affect patients’ eventual clinical decisions.
Enhanced physician ability to communicate sensitively with patients (e.g., gauging what and
when to communicate) can potentially help women make optimal decisions about these
surgeries. These decisions involve complex pros and cons. Extents of family histories, and
thus of risk, vary widely. Hence, it is difficult to say how many women should ideally
undergo surgeries. But the evidence seems to suggest that many women who might benefit
from these procedures do not now undergo them. Most importantly, it is critical that patients
make decisions that are as informed and appropriate as possible, with all of the questions
they confront addressed as sensitively as possible by providers.
These data have implications, too, for policy makers at health care institutions, insurance
companies and governmental agencies: to consider ways of facilitating optimal provider
communication. Physicians face multiple competing demands for their time, challenging
their ability to be optimally sensitive and empathetic. Reduced reimbursement rates add to
these pressures. Hence, improving insurance coverage to enable providers to have more time
to discuss these issues with patients can be vital. Potentially, on-line websites and
information can be developed with professional input to assist patients in addressing these
quandaries. In the long run, such efforts can potentially improve disease prevention and
medical outcomes.
From a theoretical perspective, these data illustrate the ways and degrees to which
interactions with physicians and others can shape key elements of the Health Belief Model
and the State of Change Model—specifically, awareness of treatment options and perceived
susceptibility. Clearly, these external inputs vary widely. Hence, it is important for future
research to explore more thoroughly aspects of these interactions as described here.
These data have several limitations. These women reported as best as they could their
perceptions and recollections of physicians’ comments, but may at times not have recalled
physicians’ comments verbatim or wholly accurately. Nonetheless, in the least, these
women’s perceptions, memories, responses and attitudes are important in and of themselves
in revealing their perspectives on interactions, and their concerns, which can prove critical.
Klitzman and Chung Page 17













Future research can attempt to explore matched dyads of patients with their actual providers.
In addition, these women provided data at one point in time, and spoke about past decisions
and operations. But these data nevertheless offer insights that future research can examine
further, longitudinally. The sample size, though relatively low for quantitative studies, is
sufficient for qualitative research, providing an in-depth sense of the range and types of
issues and phenomena that arise here. Future research can explore these issues in larger
samples, too. We have also included a range of women, both tested and untested, and those
who have not yet decided to undergo prophylactic surgery, or decided against it. Though a
critic may object that this breadth is too diverse, we found that these women were generally
aware of these issues and commented on them from their respective vantage points. For
example, wariness of prophylactic surgery led some women even to avoid testing, since they
felt they could thereby avoid having to confront these stressful surgical dilemmas.
In sum, these data illuminate a series of quandaries these patients confront, and crucial roles
that providers and others may play in addressing these dilemmas. As such, these results have
several possible implications for enhancing provider training and care, education of patients
and their families, and future research and policy.
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TABLE II
Semi-Structured Interview Guide (Sample Questions)
Have you considered or pursued any treatment or surgery for breast cancer or risk of breast cancer? If so, what and why?
How did you make those decisions?
Have healthcare providers discussed treatment issues with you? If so, what did they say?
Have you discussed treatment issues with any other people?
If so, who, when and why? What did they say?
How do you feel about interactions you have had with providers and others about these issues?
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